Jan Stern Reed is Director of STEPAN CO. Currently has a direct ownership of 11,411 shares of SCL, which is worth approximately $876,935. The most recent transaction as insider was on May 10, 2024, when has been sold 1,396 shares (Common Stock) at a price of $89.53 per share, resulting in proceeds of $124,983. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.4K
0% 3M change
13.94% 12M change
Total Value Held $876,935

JAN STERN REED Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2024
BUY
Grant, award, or other acquisition
$124,983 $89.53 p/Share
1,396 Added 10.9%
11,411 Common Stock
Apr 25 2023
BUY
Grant, award, or other acquisition
$124,973 $94.32 p/Share
1,325 Added 11.68%
10,015 Common Stock
Apr 26 2022
BUY
Grant, award, or other acquisition
-
1,249 Added 12.57%
8,690 Common Stock
Apr 27 2021
BUY
Grant, award, or other acquisition
-
760 Added 9.27%
7,441 Common Stock

Also insider at

ANGO
ANGIODYNAMICS INC Healthcare
RCEL
AVITA Medical, Inc. Healthcare
JSR

Jan Stern Reed

Director
Latham, NY

Track Institutional and Insider Activities on SCL

Follow STEPAN CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SCL shares.

Notify only if

Insider Trading

Get notified when an Stepan CO insider buys or sells SCL shares.

Notify only if

News

Receive news related to STEPAN CO

Track Activities on SCL